These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32451744)

  • 21. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer.
    Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Zdrojowy R; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Narod SA; Lubiński J
    J Med Genet; 2006 Nov; 43(11):863-6. PubMed ID: 17085682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
    Cybulski C; Huzarski T; Górski B; Masojć B; Mierzejewski M; Debniak T; Gliniewicz B; Matyjasik J; Złowocka E; Kurzawski G; Sikorski A; Posmyk M; Szwiec M; Czajka R; Narod SA; Lubiński J
    Cancer Res; 2004 Apr; 64(8):2677-9. PubMed ID: 15087378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers.
    Williams LH; Choong D; Johnson SA; Campbell IG
    Clin Cancer Res; 2006 Dec; 12(23):6967-72. PubMed ID: 17145815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
    Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
    Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.
    Näslund-Koch C; Nordestgaard BG; Bojesen SE
    J Clin Oncol; 2016 Apr; 34(11):1208-16. PubMed ID: 26884562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours.
    Sodha N; Bullock S; Taylor R; Mitchell G; Guertl-Lackner B; Williams RD; Bevan S; Bishop K; McGuire S; Houlston RS; Eeles RA
    Br J Cancer; 2002 Dec; 87(12):1445-8. PubMed ID: 12454775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes.
    Mayer F; Stoop H; Sen S; Bokemeyer C; Oosterhuis JW; Looijenga LH
    Oncogene; 2003 Jun; 22(25):3859-66. PubMed ID: 12813459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
    Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
    Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency of CHEK2 gene mutations in patients with breast cancer from the Republic of Bashkortostan].
    Mol Biol (Mosk); 2014; 48(1):55-61. PubMed ID: 25842825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.
    Kleiblova P; Stolarova L; Krizova K; Lhota F; Hojny J; Zemankova P; Havranek O; Vocka M; Cerna M; Lhotova K; Borecka M; Janatova M; Soukupova J; Sevcik J; Zimovjanova M; Kotlas J; Panczak A; Vesela K; Cervenkova J; Schneiderova M; Burocziova M; Burdova K; Stranecky V; Foretova L; Machackova E; Tavandzis S; Kmoch S; Macurek L; Kleibl Z
    Int J Cancer; 2019 Oct; 145(7):1782-1797. PubMed ID: 31050813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.
    Janiszewska H; Bąk A; Skonieczka K; Jaśkowiec A; Kiełbiński M; Jachalska A; Czyżewska M; Jaźwiec B; Kuliszkiewicz-Janus M; Czyż J; Kuliczkowski K; Haus O
    Leuk Res; 2018 Jul; 70():74-78. PubMed ID: 29902706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of gastric cancer in carriers of CHEK2 mutations.
    Teodorczyk U; Cybulski C; Wokołorczyk D; Jakubowska A; Starzyńska T; Lawniczak M; Domagała P; Ferenc K; Marlicz K; Banaszkiewicz Z; Wiśniowski R; Narod SA; Lubiński J
    Fam Cancer; 2013 Sep; 12(3):473-8. PubMed ID: 23296741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.
    Janiszewska H; Bak A; Pilarska M; Heise M; Junkiert-Czarnecka A; Kuliszkiewicz-Janus M; Całbecka M; Jaźwiec B; Wołowiec D; Kuliczkowski K; Haus O
    Haematologica; 2012 Mar; 97(3):366-70. PubMed ID: 22058216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.
    Francies FZ; Wainstein T; De Leeneer K; Cairns A; Murdoch M; Nietz S; Cubasch H; Poppe B; Van Maerken T; Crombez B; Coene I; Kerr R; Slabbert JP; Vral A; Krause A; Baeyens A; Claes KB
    BMC Cancer; 2015 Nov; 15():912. PubMed ID: 26577449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Clinical and Genetic Analysis of
    Kirchner K; Gamulin M; Kulis T; Sievers B; Kastelan Z; Lessel D
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.
    Bąk A; Janiszewska H; Junkiert-Czarnecka A; Heise M; Pilarska-Deltow M; Laskowski R; Pasińska M; Haus O
    Hered Cancer Clin Pract; 2014 Apr; 12(1):10. PubMed ID: 24713400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further Association of Germline
    Kirchner K; Seidel C; Paulsen FO; Sievers B; Bokemeyer C; Lessel D
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Landscape of Somatic Genetic Alterations in Breast Cancers from
    Mandelker D; Kumar R; Pei X; Selenica P; Setton J; Arunachalam S; Ceyhan-Birsoy O; Brown DN; Norton L; Robson ME; Wen HY; Powell S; Riaz N; Weigelt B; Reis-Filho JS
    JNCI Cancer Spectr; 2019 Jun; 3(2):pkz027. PubMed ID: 31360903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
    Hallamies S; Pelttari LM; Poikonen-Saksela P; Jekunen A; Jukkola-Vuorinen A; Auvinen P; Blomqvist C; Aittomäki K; Mattson J; Nevanlinna H
    BMC Cancer; 2017 Sep; 17(1):620. PubMed ID: 28874143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.